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Abstract: One-hundred and sixty-eight aqueous and organic extracts of 42 selected bryophyte species
were screened in vitro for antiproliferative activity on a panel of human gynecological cancer cell lines
containing HeLa (cervix epithelial adenocarcinoma), A2780 (ovarian carcinoma), and T47D (invasive
ductal breast carcinoma) cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay and for antibacterial activity on 11 strains using the disc-diffusion method. A total
of 99 extracts derived from 41 species exerted ≥25% inhibition of proliferation of at least one of
the cancer cell lines at 10 µg/mL. In the cases of Brachythecium rutabulum, Encalypta streptocarpa,
Climacium dendroides, Neckera besseri, Pleurozium schreberi, and Pseudoleskeella nervosa, more than one
extract was active in the antiproliferative assay, whereas the highest activity was observed in the
case of Paraleucobryum longifolium. From the tested families, Brachytheciaceae and Amblystegiaceae
provided the highest number of antiproliferative extracts. Only 19 samples of 15 taxa showed
moderate antibacterial activity, including the most active Plagiomnium cuspidatum, being active on
8 tested strains. Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus were the
most susceptible to the assayed species. This is the first report on the bioactivities of these 14 species.
Keywords: bryophytes; antiproliferative; antibacterial; MTT assay
1. Introduction
In the era of drug development based on high-throughput pharmacological screening, there is
an increasing demand for molecules to be tested. Besides large synthetic libraries, natural products are
of primary importance because of their pharmacological activities and high structural diversity. In the
last decades, 22% of all the newly approved drug molecules have been natural product derivatives
(semisynthetic), 4% have been genuine natural products, and 13% have been made by total synthesis
bearing the pharmacophore of a natural product [1]. Two of the most important research topics
in drug development are anticancer agents and antibiotics. According to the World Cancer Report
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2014, there were approximately 14 million new cases and 8.2 million cancer-related deaths in 2012 [2].
Although in recent years several novel strategies have been uncovered for fighting cancer, the successful
treatment of several types of cancer is still a challenge, and plants continue to play a major role in drug
discovery, as evidenced by the number of promising new agents in clinical development [3]. The burden
of microbial infections, although most devastating in developing countries, is also increasing in Western
countries as a result of spreading antibiotic resistance. Having these in mind, together with the fact
that 65% of antibiotics and 35% of anticancer agents registered between 1980 and 2010 were natural
products or semisynthetic derivatives thereof, the investigation of possible new sources for bioactive
natural products is of primary importance.
From a phytochemical and pharmacological point of view, the most thoroughly explored taxon
of the plant kingdom is vascular plants. Bryophytes (belonging to non-vascular plants) are less
well studied. Although the potential presence of bioactive secondary metabolites in these species is
suggested by the fact that generally bryophytes are not damaged by microorganisms, insects, or other
pests [4], the phytochemistry and pharmacological profiles of the majority of species are undisclosed.
The development of microscopic or genetic identification and micropropagation techniques has
triggered the research into bryophytes [5].
The bryophytes, with more than 20,000 species, comprising Marchantiophyta (liverworts,
~6000 species), Bryophyta (mosses, ~14,000 species), and Anthocerotophyta (hornworts, ~300 species),
can be found everywhere in the world except in the sea. In the Hungarian flora, 659 species are
present, with the predominance of mosses [6]. Although not applied in human nutrition, a number
of bryophytes have been widely used as medicinal plants, particularly in China for various illnesses,
including for diseases of bacterial origin [7]. In other parts of the world, the medicinal use of bryophytes
is rather sporadic.
The first reports on the antimicrobial effects of bryophytes date back to the 1940s. In the 1950s,
the remarkable antibacterial effect of some species (Anomodon rostratus, Orthotrichum rupestre, and
Plagiomnium cuspidatum) [8] attracted scientific interest, and some years later, the first extensive study on
this topic, including the analysis of 50 species, was published [9]. In a comprehensive study published
in 1979, the antibiotic activity of 52 species was examined on 8 bacterial strains; 56% of the tested species
were active against at least one of the test bacteria [10]. Since then, several bryophytes, including
the most active from the Bazzania, Conocephalum, Diplophyllum, Dumortiera, Marchantia, Metzgeria,
Lunularia, Pellia, Plagiochila, Porella, Radula, and Riccardia genera, were reported to have antimicrobial
activity [11,12]. In liverworts, essential oils may partly be responsible for this activity [13]; however,
in several cases, active components have been identified from the involatile fraction. Sacculatal from
Pellia endiviifolia showed potent antibacterial activity against Streptococcus mutans [14], lepidozenolide
from Lepidozia fauriana showed activity against methicillin-resistant Staphylococcus aureus (MRSA) [15],
and marchantins from many Marchantia species showed activity against more than 10 pathogen
bacteria [16,17]. Herbertane sesquiterpenoids were active against Staphylococcus aureus, Klebisella
pneumoniae, and Bacillus subtilis [18,19]. Chlorinated bibenzyls from Riccardia marginata exhibited
antibacterial effect against Bacillus subtilis [12]. A series of diterpenoids from the liverwort Jungermannia
exertifolia showed potent activity against the virulent Mycobacterium tuberculosis H37Rυ strain [20].
Extracts of several bryophytes and certain secondary metabolites exhibited remarkable
in vitro cytotoxicity on cancer cell lines. Terpenoids and bibenzyl derivatives have been
reported among the most potent cytotoxic compounds [21]. Sesquiterpenoids (among them,
lactones), such as plagiochiline A and its derivatives [16,22], costunolide, and related
compounds [23], exhibited cytotoxicity at micromolar and submicromolar concentrations. Certain
diterpenes, including kaurane (e.g., rabdoumbrosanin and derivatives) [24,25], pimarane [11],
and atisane-type compounds [26], were also confirmed to be active. Macrocyclic bis(bibenzyls)
such as marchantins and riccardins are characteristic compounds of bryophytes. Their in vitro
antiproliferative activities have been confirmed in several experiments [17,27]. The latter groups
of compounds—similarly to certain kaurane diterpenes [28]—exert their effects through induction of
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apoptosis [29,30] and inhibit p-glycoprotein-mediated multidrug resistance [31]. Some ent-kauranes
induced apoptosis through a caspase-8-dependent pathway [32,33]. In the case of diterpene
jungermanenones, a caspase-independent pathway, together with the inhibition of NF-κB (nuclear
factor kappa-light-chain-enhancer of activated B cells), is suggested [34]. Marchantin C, a compound
with a different structure from all the previously known microtubule inhibitors, decreased the quantity
of microtubules at the G2/M phase in human tumor cells and decreased the polymerisation rate of
tubulin, similarly to in [30,35].
The aim of our work was to carry out an extensive in vitro bioactivity assay on 42 bryophyte
species native to Hungary to identify taxa with remarkable antiproliferative and antimicrobial activities.
Further, the phytochemical and bioactivity data of the assayed species were reviewed.
2. Results
In the course of the in vitro screening for antiproliferative and antimicrobial activities,
168 extracts belonging to 42 bryophyte species, 35 genera, and 20 families were evaluated using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and the disc-diffusion
method, respectively. The antiproliferative activities of the extracts were assessed on human
cervical (HeLa), ovarian (A2780), and breast (T47D) cancer cell lines using two final concentrations
(10 and 30 µg/mL). The results of the antiproliferative assays are presented in Table 1. Extracts prepared
with n-hexane (A), CHCl3 (B), aqueous MeOH (C), and H2O (D) were investigated for their cytostatic
effects. A total of 98 extracts representing 41 species exerted ≥25% inhibition of proliferation of at
least one of the cell lines at 10 µg/mL. The numbers of active A/B/C/D fractions were 24/38/20/16,
respectively. In the case of 25 extracts (from 17 species), the inhibition was ≥50% on at least one
of the cell lines at this concentration. This higher inhibition was most characteristic to B extracts
(13), followed by A (7), C (4), and D (1). More than one extract was active in the case of six species,
namely, Brachythecium rutabulum, Climacium dendroides, Encalypta streptocarpa, Pleurozium schreberi
(A and B), Neckera besseri, and Pseudoleskeella nervosa (A, B, and C). At 30 µg/mL, 36 samples belonging
to 26 species were inactive (25 of these were D extracts); further analysis of these extracts did not seem
to be prospective. Compounds responsible for bioactivity were less polar in the analysed samples.
The highest activity (78.54% inhibition on HeLa at 10 µg/mL) was observed in the case of the B extract
of Paraleucobryum longifolium. Moreover, this extract was active on all the cell lines, and activities at
10 µg/mL were not much lower than those at 30 µg/mL (46.84–78.54% vs 56.87–83.93%). Interestingly,
in the case of this species, only the CHCl3 extract had remarkable activities. Concerning the sensitivity
of the cell lines, the measure of inhibition was more pronounced in the cases of HeLa and T47D
than A2780. On HeLa, 16 extracts; on T47D, 10 extracts; and on A2780, only 3 extracts exerted >50%
inhibition at 10 µg/mL. From the tested families, Brachytheciaceae (with Brachythecium rutabulum,
Homalothecium philippeanum, and Pseudoscleropodium purum) and Amblystegiaceae (with Amblystegium
serpens and Hygroamblystegium tenax) provided the highest numbers of active extracts.
The antimicrobial activity of the tested bryophytes, determined by the disc-diffusion method
on 11 standard strains, seemed to be sporadic and of low intensity. From the 42 tested species,
only 19 samples of 15 taxa showed moderate antibacterial activity (Table 2). None of the extracts were
active on Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 35218, and Klebsiella pneumoniae
ATCC 700603. Methicillin-resistant Staphylococcus aureus ATCC 43300 and Staphylococcus aureus ATCC
29213 proved to be the strains most susceptible to the examined species. Among the fractions with
different polarities, the relatively apolar n-hexane and chloroform extracts demonstrated antibacterial
activities. The aqueous and remnant MeOH fractions were inactive. From the tested species,
Plagiomnium cuspidatum seemed to be the most prospective for further analysis of its antibacterial
effects and constituents responsible for this activity, being active on eight tested strains.
There was a notable correlation between the antiproliferative and antimicrobial activities: 7 of the
14 species with antimicrobial activities and 7 of the 15 species with >50% inhibitory activity at 10 µg/mL
on any of the cancer cell lines also possessed the other activity. Amblystegium serpens, Brachythecium
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rutabulum, Cirriphyllum piliferum, Climacium dendroides, Paraleucobryum longifolium, Plagiomnium affine,
and Pseudoscleropodium purum were active in both assays.
Table 1. Antiproliferative activities against cancer cell lines treated with extracts for an exposure time
of 72 h; values exceeding 50% inhibition are coloured from yellow to green; extracts exerting less than
25% inhibition of cancer cell growth were considered inactive (red), and their exact results are not given
numerically; SEM (standard error of the mean) values reported in Table S1.
Species
Extract A Extract B
HeLa A2780 T47D HeLa A2780 T47D
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
Abietinella abietina <25 <25 <25 <25 <25 32.26 30.00 38.62 <25 <25 42.99 48.97
Amblystegium serpens <25 46.13 29.58 49.94 49.15 70.15 61.93 70.78 53.46 65.35 70.15 74.76
Anomodon viticulosus 26.96 50.72 <25 <25 <25 27.81 27.04 49.35 32.35 53.87 <25 36.32
Atrichum undulatum <25 <25 <25 <25 <25 41.66 59.93 76.26 37.78 64.28 64.11 65.26
Barbula unguiculata 45.74 63.27 <25 <25 <25 34.14 65.46 75.11 <25 47.47 44.20 53.16
Brachytheciastrum
velutinum 31.92 64.96 <25 35.58 <25 41.01 34.43 55.09 <25 61.29 34.43 51.51
Brachythecium
rutabulum 53.49 61.64 25.04 34.93 45.40 55.36 51.95 53.89 <25 35.30 46.79 54.92
Bryum argenteum 47.79 80.09 <25 <25 <25 <25 36.11 54.52 <25 <25 35.95 41.26
Bryum caespiticium 30.37 57.84 <25 <25 <25 48.80 48.64 59.57 <25 <25 28.58 48.17
Bryum moravicum <25 38.27 <25 <25 <25 29.73 46.72 62.09 27.34 48.22 40.64 59.69
Calliergonella cuspidata <25 <25 <25 <25 <25 <25 <25 32.79 <25 <25 39.02 49.49
Ceratodon purpureus <25 26.67 <25 32.49 <25 28.88 30.67 42.00 <25 35.18 <25 28.48
Cirriphyllum piliferum 51.34 67.39 <25 42.24 <25 31.19 <25 28.32 <25 <25 <25 <25
Climacium dendroides 52.79 63.79 <25 32.63 <25 <25 56.79 64.89 <25 <25 55.46 57.16
Dicranum tauricum <25 <25 <25 28.55 <25 31.60 33.14 51.60 <25 48.94 35.38 54.93
Encalypta streptocarpa 76.66 61.32 34.04 87.90 25.72 44.08 54.46 72.90 73.72 80.12 33.22 33.27
Funaria hygrometrica <25 39.84 <25 <25 <25 36.21 48.44 62.88 25.66 51.06 46.44 53.18
Homalothecium
lutescens <25 37.79 <25 31.59 <25 30.29 <25 <25 <25 <25 28.74 30.64
Homalothecium
philippeanum 38.34 63.66 <25 40.77 37.39 48.19 46.93 73.77 33.60 74.93 63.90 62.51
Hygroamblystegium
tenax <25 51.08 <25 26.53 28.34 43.75 36.99 43.86 <25 <25 49.19 55.28
Leskea polycarpa <25 29.00 <25 37.18 <25 25.71 <25 31.32 <25 35.02 <25 37.07
Leucodon sciuroides 26.00 43.88 <25 <25 <25 34.43 42.48 61.74 <25 <25 28.88 39.63
Neckera besseri 54.29 68.98 <25 <25 33.72 38.33 69.13 83.28 <25 76.48 50.07 68.26
Orthotrichum
diaphanum <25 28.22 <25 <25 <25 <25 40.19 51.75 25.04 50.65 35.43 40.61
Oxyrrhynchium hians <25 50.41 <25 42.22 26.03 46.46 25.65 39.79 <25 28.61 34.01 46.64
Paraleucobryum
longifolium <25 27.34 <25 <25 <25 <25 78.54 83.93 63.23 78.03 46.84 56.87
Plagiomnium affine <25 41.79 <25 <25 <25 <25 42.41 55.53 <25 42.11 42.49 56.05
Plagiomnium
cuspidatum 39.13 39.44 26.49 97.60 <25 86.33 <25 <25 <25 56.15 <25 36.11
Plagiomnium rostratum 26.01 60.72 <25 44.99 28.68 36.26 46.52 60.22 43.23 67.06 45.56 54.59
Plagiomnium
undulatum 35.77 33.42 <25 26.07 29.36 43.49 <25 <25 <25 33.21 <25 32.10
Pleurozium schreberi 61.85 93.41 41.15 37.25 <25 31.65 60.49 74.30 <25 36.89 29.26 43.95
Pohlia nutans <25 <25 <25 <25 <25 <25 29.51 49.60 <25 <25 <25 <25
Polytrichastrum
formosum <25 34.69 <25 <25 <25 28.85 <25 34.18 <25 <25 <25 <25
Porella platyphylla 31.89 79.22 48.22 83.33 48.94 64.37 35.69 47.36 <25 41.93 29.33 47.86
Pseudoleskeella nervosa 68.43 75.64 <25 <25 38.94 43.69 61.71 71.88 <25 36.28 42.77 45.50
Pseudoscleropodium
purum <25 34.16 <25 <25 <25 <25 62.06 70.27 <25 28.01 53.88 54.58
Rhytidiadelphus
squarrosus <25 <25 <25 <25 <25 <25 43.99 53.66 <25 <25 40.31 51.65
Rhytidium rugosum 32.34 56.50 <25 36.29 <25 25.80 30.20 39.48 <25 <25 <25 27.52
Schistidium crassipilum <25 33.32 <25 <25 <25 <25 27.52 53.09 <25 72.36 <25 38.36
Syntrichia ruralis <25 <25 <25 <25 <25 <25 27.05 33.02 <25 <25 30.49 39.25
Thamnobryum
alopecurum 29.98 57.12 <25 26.75 <25 <25 34.35 53.87 <25 51.91 <25 <25
Thuidium assimile <25 <25 <25 29.18 <25 <25 43.36 57.09 34.62 58.86 65.70 56.12
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Table 1. Cont.
Species
Extract C Extract D
HeLa A2780 T47D HeLa A2780 T47D
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
10
µg/mL
30
µg/mL
Abietinella abietina 35.25 52.48 <25 <25 38.22 49.01 <25 <25 <25 <25 <25 30.04
Amblystegium serpens 33.19 44.83 <25 26.71 48.58 58.34 <25 <25 <25 <25 27.91 35.73
Anomodon viticulosus <25 34.02 <25 <25 <25 27.47 <25 <25 <25 <25 <25 <25
Atrichum undulatum 29.14 41.65 <25 46.14 <25 37.95 33.37 36.14 <25 <25 <25 <25
Barbula unguiculata 29.68 35.91 <25 <25 <25 27.68 27.92 27.4 <25 <25 <25 <25
Brachytheciastrum
velutinum <25 32.09 <25 <25 27.26 34.7 34.9 34.68 <25 <25 38.53 38.46
Brachythecium
rutabulum <25 34.26 <25 <25 <25 34.81 <25 <25 <25 <25 <25 <25
Bryum argenteum <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Bryum caespiticium <25 35.57 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Bryum moravicum <25 37.94 <25 <25 <25 26.51 <25 <25 <25 <25 <25 <25
Calliergonella cuspidata <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Ceratodon purpureus <25 <25 <25 <25 <25 31.86 <25 <25 <25 <25 <25 <25
Cirriphyllum piliferum 28.18 42.07 <25 <25 <25 26.85 <25 32.27 <25 <25 <25 <25
Climacium dendroides <25 <25 <25 <25 <25 27.68 <25 27.42 <25 <25 27.38 37.52
Dicranum tauricum <25 28.29 <25 <25 33.52 49.97 29.75 37.11 <25 <25 45.31 47.21
Encalypta streptocarpa 28.01 39.61 <25 <25 <25 32.5 27.05 <25 <25 <25 <25 <25
Funaria hygrometrica <25 <25 <25 <25 42.27 48.22 25.11 38.47 <25 <25 35.4 45.16
Homalothecium
lutescens <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 27.6
Homalothecium
philippeanum <25 33.51 <25 28.04 43.32 51 <25 <25 <25 <25 33.68 41.04
Hygroamblystegium
tenax 26.66 38.22 <25 <25 52.69 55.03 <25 31.71 <25 <25 37.34 40.38
Leskea polycarpa 25.62 31.09 <25 <25 <25 34.12 <25 <25 <25 <25 <25 <25
Leucodon sciuroides <25 29.98 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Neckera besseri 37.13 41.25 <25 <25 54.5 55.63 <25 <25 <25 <25 32.28 43.28
Orthotrichum
diaphanum <25 40.79 <25 <25 <25 28.2 <25 <25 <25 <25 <25 <25
Oxyrrhynchium hians <25 <25 <25 <25 <25 29.53 <25 <25 <25 <25 <25 <25
Paraleucobryum
longifolium <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Plagiomnium affine 42.04 50.67 <25 26.86 53.3 57.53 <25 <25 <25 <25 <25 <25
Plagiomnium
cuspidatum 35.49 46.35 <25 <25 33.53 45.9 <25 <25 <25 <25 <25 27.79
Plagiomnium rostratum 40.44 51.65 <25 42.42 33.23 45.84 <25 <25 <25 <25 <25 <25
Plagiomnium
undulatum <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Pleurozium schreberi <25 32.99 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Pohlia nutans <25 32.63 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Polytrichastrum
formosum <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Porella platyphylla <25 41.69 <25 <25 <25 27.66 <25 <25 <25 <25 <25 <25
Pseudoleskeella nervosa 60.51 65.03 <25 26.27 49.89 54.5 <25 <25 <25 <25 <25 25.43
Pseudoscleropodium
purum <25 28.06 <25 <25 <25 31.29 <25 29.89 <25 <25 32.22 40.05
Rhytidiadelphus
squarrosus <25 26.56 <25 <25 <25 33.78 <25 <25 <25 <25 <25 <25
Rhytidium rugosum <25 33.67 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Schistidium crassipilum <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25 <25
Syntrichia ruralis <25 <25 <25 <25 <25 <25 30.83 41.17 <25 <25 57.42 59.35
Thamnobryum
alopecurum <25 31.9 <25 <25 <25 <25 26.26 40.68 <25 <25 <25 <25
Thuidium assimile <25 <25 <25 34.23 29.78 43.24 <25 <25 <25 <25 32.28 44.58
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Table 2. Antibacterial activities of moss extracts (inhibition zones in millimetres).
Species Extract
MRSA S.aureus
S.
epidermidis
B.
subtilis
S.
pyogenes
S.
pneumoniae
S.
agalactiae
M.
catarrhalis
ATCC
43300
ATCC
29213
ATCC
12228
ATCC
6633
ATCC
19615
ATCC
49619
ATCC
13813 ATCC 43617
Amblystegium serpens B — — — — — — — 9.0
Brachythecium rutabulum B 9.0 9.0 — — — — — —
Calliergonella cuspidata A — 7.3 — — — — — —
B — 7.0 — — — — — —
Cirriphyllum piliferum B — — — — — 7.0 — —
Climacium dendroides A — 7.3 — — — — — —
Dicranum tauricum B — — — — — 8.0 — —
Oxyrrhynchium hians A 8.6 8.6 — — — — — —
B — 8.0 — — — — — —
Paraleucobryum longifolium B 9.6 9.6 — — 11.6 — — —
Plagiomnium affine B — — — 8.0 — 8.5 — —
Plagiomnium cuspidatum A 11.3 10.7 9.0 9.0 10.0 12.0 10.0 10.0
B 7.6 7.6 — — — — — —
Plagiomnium undulatum A 7.0 8.0 — — — — — —
B — 8.0 — — — — — —
Pseudoscleropodium purum A — 7.3 — — — — — —
Rhytidium rugosum B — — — 7.5 — 8.0 — 7.5
Schistidium crassipilum B 8.0 7.0 — 9.0 — 11.5 — 7.7
For 14 species active in either of the assays, no chemical or pharmacological data are available in
the literature (Amblystegium serpens (Hedw.) Schimp., Barbula unguiculata Hedw., Bryum caespiticium
Hedw., Cirriphyllum piliferum (Hedw.) Grout, Dicranum tauricum Sapjegin, Encalypta streptocarpa
Hedw., Hygroamblystegium tenax (Hedw.) Jenn., Neckera besseri (Lobarz.) Jur., Oxyrrhyncium hians
(Hedw.) Loeske, Paraleucobryum longifolium (Hedw.) Loeske, Pseudoleskeella nervosa (Brid.) Nyholm,
Schistidium crassipilum H. H. Blom, Syntrichia ruralis (Hedw.) F. Weber & D. Mohr, and Thuidium
assimile (Mitt.) A. Jaeger) (Table 3). Ethnopharmacological data are scarce. Barbula unguiculata
has been used as an analgesic and to reduce fever, and Bryum argenteum has been used as an
antipyretic and as an antifungal agent in folk medicine [36]. The available data on biologically active
species generally do not confirm or support our observations. In Anomodon viticulosus, previously
only fatty acids were detected [37,38]; there are no data in literature on its antiproliferative and
antimicrobial effects. In the case of Atrichum undulatum, the presence of the reported sterols [38],
carotenoids [38], and fatty acids [39] may not be related to the antiproliferative activity; however,
coumarin glycosides [40] may have some role in this effect. The DMSO (dimethyl sulfoxide) and
aqueous extracts of this species were active against certain bacteria [41,42]; however the extracts
analysed by us did not have such an effect. For Brachytheciastrum velutinum, only the presence of
phenolic acids and flavonoids has been reported [43]. Brachythecium rutabulum possessed remarkable
antibacterial activity [44], including against Staphylococcus aureus, as also demonstrated in our
experiments. Bryum argenteum, with a confirmed flavonoid content [45,46], was reported to be active
against different bacterial and fungal strains [8,47,48]. However, in our antimicrobial assay, it was
not active. For Calliergonella cuspidata, only the presence of fatty acids [49] and antioxidant activity
was reported [50], with no reference to the antimicrobial activity first observed by us. In the case of
Climacium dendroides, both antiproliferative and antimicrobial effects have been reported [51]. From the
secondary metabolites of this species, flavonoids and chromenones [51,52] might be related with these
activities; however, the role of these compounds has not been investigated. Homalothecium philippeanum
was antiproliferative in our assay but, contrary to previous results [53], exerted no antibacterial
activity against Staphylococcus aureus. From Plagiomnium affine, which was active in both of our assays,
only the presence of flavonoids has been reported previously [54]. Two other Plagiomnium species
(P. cuspidatum and P. undulatum) had antimicrobial activities in our tests, with literature references
only to their flavonoid contents [55–58]. In contrast to previous reports [53,59], Pleurozium schreberi did
not exert antimicrobial activity. The sesquiterpene and flavonoid content of Porella platyphylla [60–63]
may be related to its antiproliferative activity, but there are no reports on the anticancer effect of
this species. From Pseudoscleropodium purum, only sterols, triterpenes, and essential oil have been
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reported [64–66]. The antimicrobial activity of Rhytidium rugosum was reported previously [53]. As part
of our experiments, we carried out an LC-MS-based characterisation of the most biologically active
extracts. Altogether, 58 compounds were identified from 9 different extracts (Table S4), the majority of
which were acids and terpenoids. The limitation of this approach was that it allowed the identification
of already known compounds. Further experiments will aim at the isolation and identification of
bioactive constituents.
Table 3. Literature data on the chemistry (C) and bioactivities (B) of the studied species.
Species (Family) Bioactivity
Abietinella abietina (Hedw.) M. Fleisch.
(Thuidiaceae)
C Fatty acids (main components: oleic, palmitic, and linoleic acid) [67];sterols (sitosterol, stigmasterol, and campesterol) [67,68]
B
Antimicrobial effect with MIC (minimum inhibitory concentration) values
of 1.25–10 mg/mL against Gram-positive (Staphylococcus aureus, Micrococcus
flavus, and Bacillus cereus) and Gram-negative (Escherichia coli and Salmonella
typhimurium) bacteria and fungi (Trichoderma viride, Penicillium funiculosum,
Penicillium ochrochloron, Aspergillus flavus, A. niger, and A. fumigatus) [69]
Anomodon viticulosus (Hedw.)
Hook. & Taylor
(Thuidiaceae)
C Fatty acids (linoleic acid, nonadecanoic acid, palmitic acid, and behenicacid) [37,38]
Atrichum undulatum (Hedw.) P. Beauv.
(Polytrichaceae)
C
Sterols (major: 24-methylcholesterol and 24-ethyl-22-dehydrocholesterol)
[38]; carotenoids (β-carotene, lutein, violaxanthin, and neoxanthin) [38];
fatty acids (major: linoleic acid, α -linolenic acid, palmitic acid, oleic acid,
and arachidonic acid) [39]; coumarin glycosides [40]
B
Antimicrobial effect of DMSO extracts with MIC values of
0.5–3.0 mg/mL against eight bacterial species (Escherichia coli, Pseudomonas
aeruginosa, Salmonella typhimurium, Enterobacter cloacae, Listeria
monocytogenes, Bacillus cereus, Micrococcus flavus, and Staphylococcus aureus)
[41]; aqueous extract active against Staphylococcus aureus [42]; weak
antioxidant activity in vitro [70]
Brachythecium rutabulum (Hedw.) Schimp.
(Brachytheciaceae)
C Polyunsaturated fatty acids [71]
B
The EtOH extract active against the bacteria Micrococcus luteus, Bacillus
subtilis, Bacillus cereus, Enterobacter aerogenes, Escherichia coli, Klebsiella
pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus,
Salmonella typhimurium, and Streptococcus pneumoniae and the fungi Candida
albicans, Cryptococcus albidus, Trichophyton rubrum, Aspergillus niger, and
Aspergillus flavus with MIC values of 0.19–1.56 µg/mL [44]; antioxidant
activity [50]
Brachytheciastrum velutinum (Hedw.)
Ignatov & Huttunen
(Brachytheciaceae)
C
Phenolic acids (4-O-caffeoylquinic, 5-O-caffeoylquinic, and caffeic and
ellagic acids) and flavonoids (apigenin-7-O-glucoside, luteolin, and
apigenin) [43]
Bryum argenteum Hedw.
(Bryaceae)
C
Major flavonoid glycosides in Antarctic B. argenteum samples apigenin and
luteolin glucosides and their 6”-malonyl esters, and the
7-O-glucosides of 8-hydroxyapigenin and 8-hydroxyluteolin [45]; luteolin
and apigenin content between 0.1 and 0.6 mg/g [46]
B
In vitro antimicrobial effects of different extracts against Bacillus cereus,
Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus
aureus, Enterococcus faecalis, Enterobacter aerogenes, and Proteus mirabilis.
Highest activity against E. coli and S. aureus (MICs of 30–70 µg/mL) [47]; no
activity of different extracts against Staphylococcus aureus, Salmonella
pullorum, Phytomonas phaseoli, Candida albicans, Salmonella paratyphi,
Micrococcus flavus, Shigella flexneri, Micrococcus rubens, or Streptococcus
pyogenes [8]; an EtOH extract exerted antimicrobial activity on Escherichia
coli, Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Aspergillus
niger, Penicilliumo chrochloron, Candida albicans, and Trichophyton
mentagrophyes with MICs of 0.10–0.41 mg/mL [48]
Bryum moravicum Podp.
(Bryaceae)
C High α-linolenic acid content [72]
B Moderate antioxidant activity in vitro [73]
Calliergonella cuspidata (Hedw.) Loeske
(Hypnaceae)
C Fatty acids (major: palmitic acid, stearic acid, oleic acid, and linolenic acid[49]
B Weak antioxidant activity in vitro [50]
Ceratodon purpureus (Hedw.) Brid.
(Ditrichaceae)
C
Flavonoid (lutelolin) [74]; polyacetylenes [75]; fatty acids (Ω-3 and -6) [38];
five new isopimarane diterpenes—smardaesidins A–E—and two new
20-nor-isopimarane diterpenes—smardaesidins F and G—together with
sphaeropsidins A and C–F were isolated from an endophytic fungal strain,
Smardaea sp. AZ0432, obtained from Ceratodon purpureus [76]
B
A MeOH extract with moderate effect against methicillin-resistant
Staphylococcus aureus [59]; moderate antioxidant activity of the EtOH
extract, independent from the total phenolic content [77]; sphaeropsidin A
and D cytotoxic on different cancer cell lines, and sphaeropsidin A
inhibited the migration of metastatic breast adenocarcinoma
(MDA-MB-231) cells at subcytotoxic concentration [76]
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Table 3. Cont.
Species (Family) Bioactivity
Homalothecium philippeanum
(Spruce) Schimp.
(Brachytheciaceae)
B
MeOH extract had antibacterial activity against Staphylococcus aureus,
Escherichia coli, Micrococcus flavus, and Salmonella typhimurium (MICs of 5
mg/mL) and antifungal activity against Aspergillus niger, A. ochraceus, A.
versicolor, Penicillium funiculosum, Trichoderma viride, and Candida albicans
(MICs of 0.5–2.5 mg/mL) [53]
Climacium dendroides (Hedw.)
F. Weber & D. Mohr(Climaciaceae)
C
Sterols (major: sitosterol, stigmasterol, and campesterol) [67]; organic acids
and flavonoid (apigenin) [51]; chromenone derivatives and flavonoids
(kaempferol and quercetin glycosides) [52]
B
EtOH extract with weak antiproliferative effect on different animal and
human cancer cell lines and remarkable antimicrobial activity against
Escherichia coli, Bacillus cereus, and Staphylococcus aureus [51]
Funaria hygrometrica Hedw.
(Funariaceae)
C Bracteatin, as the first higher plant pigment in mosses, was isolated fromthis species [78]
B Different extracts had weak antimicrobial activities against Bacillus subtilis,Pseudomonas aeruginosa, and Staphylococcus aureus [79]
Homalothecium lutescens (Hedw.) H. Rob.
(Brachytheciaceae)
C Flavonoids (3
′,3”′-binaringenin and the newly discovered 2,3-dihydro
3′,3”′-biapigenin) [80]
B The essential oil was active against the fungi Candida albicans andSaccharomyces cerevisiae [81]
Leucodon sciuroides (Hedw.) Schwägr.
(Leucodontaceae)
C
Oxylipins (oct-1-en-3-ol, (Z)-octa-1,5-dien-3-ol, (Z)-non-2-enal,
(E)-non-2-enal, (Z)-non-3-enal, and 16-(2E,6Z)-nona-2,6-dienal); essential oil
with nonanal and heptanal as main constituents [82]
B
The MeOH extract had weak to moderate antimicrobial effect against the
bacteria Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas
aeruginosa, Salmonella typhimurium, Staphylococcus aureus, Streptococcus
pyogenes, and Mycobacterium smegmatis and the fungi Candida albicans,
Rhodotorula rubra, and Kluyveromyces fragilis [83]; essential oil showed
activity against Candida albicans [82]
Plagiomnium affine
(Blandow ex Funck) T. J. Kop.
(Mniaceae)
C Flavonoids (apigenin, vitexin [55], isoorientin, isoorientin3′-O-sophoroside, and isoorientin 3′-O-neohesperidoside [54])
Plagiomnium cuspidatum
(Hedw.) T. J. Kop.
(Mniaceae)
C
Flavonoids (saponarine [55]; the 6-C-glucosyl-7-O-glucosides of apigenin,
luteolin, and chrysoeriol; and apigenin-7-O-neohesperidoside [56]) and the
new dihydrobiflavone 2,3-dihydro-5′-hydroxyamentoflavone,
2,3-dihydro-5′,3′”-dihydroxyamentoflavone, and
2,3-dihydro-5′-hydroxyrobustaflavone [56]
Plagiomnium undulatum (Hedw.) T. J. Kop.
(Mniaceae) C
Flavonoids (the biflavonoids 2,3-dihydro-5′-hydroxyrobustaflavone and
2,3-dihydro-5′-hydroxyamentoflavone; the new 3′”-desoxydicranolomin,
2,3-dihydro-3′”-desoxydicranolomin, and
2,3-dihydro-5′,3′”-dihydroxyrobustaflavone [57]; the flavone
di-C-glycosides schaftoside, isoschaftoside, neoschaftoside,
neosisoschaftoside, vicenin-2, and a chrysoeriol
6-C-arabinosyl-8-C-hexoside [58]); essential oil with sesquiterpene
hydrocarbons, including γ-elemene as major constituent [84]
Pleurozium schreberi (Willd. ex Brid.) Mitt.
Hylocomiaceae
C Apigenin and apigenin-7-rhamnoglucoside [85]
B
The MeOH extract had weak to moderate activity against Staphylococcus
aureus, methicilline-resistant Staphylococcus aureus, Bacillus subtilis, and
Enterococcus faecalis [59]
The MeOH extract was moderately active against Staphylococcus aureus, S.
epidermidis, Micrococcus flavus, Bacillus subtilis, Escherichia coli, Enterobacter
cloacae, and Salmonella typhimurium (MICs of 10-25 mg/mL) and had strong
antifungal activity (MIC of 0.5 mg/mL and minimal bactericidal
concentration of 2.5–5.0 mg/mL) against Aspergillus niger, A. ochraceus, A.
versicolor, A. flavus, Penicillium funiculosum, Trichoderma viride, and Candida
albicans [53]; the EtOH extract had weak antioxidant activities in different
test systems [70]
Pohlia nutans (Hedw.) Lindb.
(Bryaceae) C
Essential oil with nonanal and 2E-tetradecen-1-ol
as major constituents [81]
Polytrichastrum formosum
(Hedw.) G. L. Sm.
(Polytrichaceae)
B Insecticidal activity of the hexane extract against Sitophilus granaries [86]
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Porella platyphylla (L.) Pfeiff.
(Porellaceae)
C
Three new pinguisane-type sesquiterpenes (pinguisanin, pinguisanolide,
and β-pinguisenediol) and the previously known deoxopinguisone [60]; a
new pinguisanoic acid sesquiterpenoid derivative—methyl
2a-hydroxy-6-oxo-11-pinguisanoate—and a new sacculatane diterpenoid
hemiacetal—(5S,9S,
10R,13S)-ll,13-epoxy-8(12),17-sacculatadiene-13β,15ζ-diol[(13S)-15
ζ-hydroxysacculaporellin]—as well as three known pinguisanes
(pinguisanin, β-pinguisenediol, and porellapinguisanolide) and the known
sacculataneperrottetianal B [61]; flavonoids (isovitexin, saponarin,
apigenin-6,8-di-C-glycoside [62], schaftoside, vicenin, and isovitexin [63]);
perrottetianal B, phytol, and stigmasterol l [87]
B Antinociceptive effect of the ether extract (main components: pinguisaninand spiropinguisanine) [88]
Pseudoscleropodium purum
(Hedw.) M. Fleisch.(Brachytheciaceae) C
Sterols (24-methyl-5-cholestenol, 24-ethyl-5-cholestenol, and
24-ethyl-5,22-cholestadienol) [64], cyclolaudenol, 31-norcyclolaudenol,
campesterol, stigmasterol, and β-sitosterol; the triterpenes hopene,
22(29)-hopene, and ursolic acid [65]; essential oil with the major
components α-pinene, β-longipinene, and heptanal [66]
Rhytidiadelphus squarrosus
(Hedw.) Warnst.
(Hylocomiaceae)
C
Sterols (24-methyl-5-cholestenol, 24-ethyl-5-cholestenol, and
24-ethyl-5,22-cholestadienol) [64]; flavonoids (the new biflavone
5′-hydroxyrobusta-flavone and the biflavonoids
5′-hydroxyamentoflavone,5′,3′”-dihydroxyamento-flavone and
2,3-dihydro-5′-hydroxyamentoflavone) [89]
B The EtOH extract inhibited the growth of Staphylococcus aureus in vitro [89]
Rhytidium rugosum (Hedw.) Kindb.
(Hylocomiaceae)
C
The major compounds of the essential oil were n-hexadecanoic acid,
linolenic acid, and cis-9- and cis-12-octadecadienoic acid. In the diethyl
ether extract, ethyl oleate and τ-sitosterol were the most abundant [90]
B
The MeOH extract exhibited antibacterial effect on Staphylococcus aureus
and Micrococcus flavus (MIC of 5 mg/mL) and antifungal activity against
Aspergillus niger, A. ochraceus, A. versicolor, A. flavus, Penicillium funiculosum,
Trichoderma viride, and Candida albicans with MIC values of 0.5–2.5 mg/mL
[53].
3. Discussion
The present investigation aimed at screening for antiproliferative and antimicrobial activities
of selected bryophytes collected in Hungary. Our results and the lack of extensive scientific
data on biologically active species suggest the necessity of further phytochemical and biological
investigations. For the 14 species having antiproliferative or antimicrobial effects, this is the first report
on their bioactivities.
4. Materials and Methods
4.1. Plant Material
Bryophytes were collected in the Northern Medium Mountains (Hungary) in September and
October of 2014 and were identified by Péter Szu˝cs. Voucher specimens for each plant were deposited
at the herbarium of the Institute of Pharmacognosy, University of Szeged. Extracts were prepared
according to the method described previously [91]. Briefly, air-dried, powdered plant material was
extracted using MeOH with the use of an ultrasonic bath. After filtration and evaporation, the residues
were dissolved in 50% aqueous MeOH and subjected to solvent–solvent partition between n-hexane
(extracts A) and CHCl3 (extracts B), and the remnant gave extracts C. The residual plant materials were
dried and extracted with boiling H2O. The filtered extracts were freeze-dried, affording extracts D.
4.2. Antiproliferative Assay
The antiproliferative properties of the prepared extracts were determined by means of the
MTT assay on a panel of human adherent cancerous cell lines of gynaecological origin containing
A2780, HeLa, and T47D cells isolated from ovarian, cervical, and breast carcinomas, respectively.
All the cells were purchased from ECACC (European Collection of Authenticated Cell Cultures,
Salisbury, U.K.) and were cultivated in minimal essential medium supplemented with 10% fetal
bovine serum, 1% non-essential amino acids, and an antibiotic–antimycotic mixture. All media and
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supplements were obtained from Lonza Group Ltd. (Basel, Switzerland). The cells were maintained
at 37 ◦C in humidified atmosphere containing 5% CO2. Near-confluent cancer cells were seeded
onto a 96-well microplate (5000 per well) and attached to the bottom of the well overnight. On the
second day, 200 µL of new medium containing the tested substances (at 10 or 30 µg/mL) was added.
After incubation for 72 h, the living cells were assayed by the addition of 20 µL of 5 mg/mL MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution. MTT was converted by intact
mitochondrial reductase and precipitated as blue crystals during a 4 h contact period. The medium
was then removed, and the precipitated crystals were dissolved in 100 µL of DMSO during a 60
min period of shaking at 25 ◦C. Finally, the reduced MTT was assayed at 545 nm using a microplate
reader; wells with untreated cells were used as controls [92]. All experiments were carried out on two
microplates with at least five parallel wells. Stock solutions of the tested substances (10 mg/mL) were
prepared with DMSO. The highest DMSO content of the medium (0.3%) did not have any substantial
effect on the cell proliferation. Cisplatin (Ebewe Pharma GmbH, Unterach, Austria), a clinically utilised
anticancer drug, was used as a reference agent. The IC50 values of its antiproliferative action were
12.43, 1.30, and 9.78 µM against HeLa, A2780, and T47D cells, respectively.
4.3. Antimicrobial Assay
Antibacterial activities of the extracts against standard bacterial strains were screened for
their inhibition zones by the standard disc-diffusion method described previously [93]. The test
microorganisms used in this study were 11 international control standard strains. The standard
Gram-positive strains were, namely, Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 29213),
Staphylococcus epidermidis (ATCC 12228), Streptococcus agalactiae (ATCC 13813), Streptococcus pneumoniae
(ATCC 49619), Streptococcus pyogenes (ATCC 19615), and methicillin-resistant Staphylococcus aureus
(ATCC 43300). The standard Gram-negative strains were, namely, Escherichia coli (ATCC 35218),
Klebsiella pneumoniae (ATCC 700603), and Moraxella catarrhalis (ATCC 43617). Microbial cultures were
grown on standard Mueller-Hinton agar plates or Columbia agar +5% sheep blood (COS) plates
(bioMérieux, Marcy-l’Étoile, France) at 37 ◦C under an aerobic or 5% CO2 environment. The strains
were stored in Cryobank vials (MAST Diagnostica, Rheinfeld, Germany) at −70 ◦C and maintained at
4 ◦C throughout the study to use as stock cultures. Briefly, bryophyte extracts were dissolved in DMSO
(Sigma-Aldrich, St. Louis, MO, USA) or water at a concentration of 50 mg mL−1. The sterile filter paper
discs (6 mm in diameter) impregnated with the extracts (10 uL of redissolved extracts) were placed on
the plate seeded with the respective bacterial suspensions (inoculums: 0.5 McFarland, 1–2 × 108 CFU
mL−1). The solvent (DMSO) served as the negative control, while ampicillin, erythromycin, imipenem,
cefuroxime, and vancomycin antibiotic susceptibility discs were used as the positive control. The plates
were incubated at 37 ◦C for 24 h under aerobic or 5% CO2 conditions. The diameters of inhibition
zones produced by the extracts (including the disc) were measured and recorded. All experiments
were carried out in triplicate.
4.4. Phytochemical Characterisation of the Extracts
The most active samples were analysed phytochemically by LC-MS. Samples were filtered
through 0.45 µm PTFE (polytetrafluoroethylene) syringe filters before analysis. For separation,
Kinetex (Phenomenex; XB-C18 and Phenyl-Hexyl, 2.1 × 100 mm, 2.6 um, 100 Å) columns were
used. The eluents were the following: A: 0.1% formic acid in MS-grade water; B: 0.1% formic acid in
MS-grade acetonitrile. The separation was done with a linear gradient from 5% to 95% B in 35 min
with a 0.3 mL/min flow rate. The HPLC instrument was an Agilent 1100 series model consisting of
a binary pump, a thermostated autosampler, and a column compartment. The mass spectrometer
was a Thermo Q-Exactive Plus Orbitrap equipped with a HESI-II ion source. The mass accuracy was
0.25+/−0.01 ppm in the positive mode and 0.34+/−0.05 in the negative mode at the mass calibration
just before the experiment. Acquisition was done in the data-dependent MS2 scan mode by altering the
charge state (positive/negative). The survey scan mass range was set to m/z 80–1000, using the lock
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masses from the known background ions listed in Table S2. The data-dependent method parameters
are shown in Table S3. The acquired MS2 peak lists were converted to a text file by using the msConvert
tool (Proteowizard), and the top 100 MS survey scan peaks were chosen for MS2 identification against
KEGG’s small-molecule database, using the MetFrag online search tool. The hits were filtered manually
using an 80% matched peak result when the number of MS2 fragment peaks was at least five.
Supplementary Materials: The following are available online: Table S1: Antiproliferative activities against cancer
cell lines treated with extracts A–D for an exposure time of 72 h (mean ± SEM); Table S2: The used lock masses
and the charge state mode; Table S3: Parameters of the data-dependent acquisition in both charge states; Table S4:
Compounds identified by LC-MS.
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